Ramaphosa welcomes first vaccines arriving in South Africa

JOHANNESBURG (Reuters) - South African President Cyril Ramaphosa hailed the arrival of the first doses of COVID-19 vaccine on Monday as a chance to “turn the tide” on a disease that has devastated the country.

FILE PHOTO: President Cyril Ramaphosa delivers his State of the Nation address at parliament in Cape Town, South Africa, February 13, 2020. REUTERS/Sumaya Hisham

Once testing of the batches is completed, the first shots will be given to health workers, who have been stretched during a second wave of infections and have been critical of the government for not securing supplies sooner.

Ramaphosa and other top officials were at the OR Tambo international airport to receive the 1 million shots of the AstraZeneca vaccine, produced by the Serum Institute of India (SII).

“The arrival of these vaccines contains the promise that we can turn the tide on this disease that has caused so much devastation and hardship in our country and across the world,” Ramaphosa said in an address to the nation.

South Africa has recorded the most COVID-19 infections and deaths on the African continent, at more than 1.4 million cases and over 44,000 deaths to date.

Since late last year, it has battled a more contagious virus variant called 501Y.V2 that has also been detected in countries in Europe, the Americas and Asia.

The shots that arrived on Monday will be checked over roughly 10 to 14 days before inoculations can begin.

The SII is due to send another 500,000 doses later this month, but more will be needed to cover South Africa’s 1.25 million health workers, as the AstraZeneca/Oxford University vaccine is administered in two doses.


Officials say the country has secured more than 50 million vaccine doses via bilateral negotiations with pharmaceutical companies, the COVAX vaccine distribution scheme co-led by the World Health Organization and an African Union arrangement.

That is almost enough to vaccinate its target of 40 million people, or two-thirds of the population, this year, given that a sizeable portion of the shots it expects to receive are of the Johnson & Johnson vaccine, which is administered in one dose.

Other African countries are more reliant on COVAX or the AU to deliver doses, and the majority are yet to receive their first vaccine shipments.

The Biovac Institute, the company that will store and distribute the first 1 million doses, has beefed up security and made backup plans in case there are power outages, its Chief Executive Morena Makhoana told Reuters.

A random sample of vaccine vials will be sent to Bloemfontein for quality assurance by medical regulator SAHPRA, Makhoana added.

Ramaphosa said COVAX would release 2 million doses by March, while shots developed by Pfizer and Johnson & Johnson doses will start to be delivered in the second quarter.

The National Treasury estimates it could cost up to 24 billion rand ($1.6 billion) to vaccinate 40 million South Africans.

Additional reporting by Wendell Roelf; Editing by Olivia Kumwenda-Mtambo, Mike Collett-White and Alison Williams